Healthinn develops ReHand, a tablet‑adapted telerehabilitation app focused on wrist, hand and finger rehabilitation that integrates current sensorimotor evidence and allows clinicians to prescribe and monitor treatments. The product was built by a team of healthcare professionals and engineers and after more than three years of development has completed clinical trials with over 600 patients. Trials with partners such as the Andalusian Public Health System and Ibermutua showed ReHand is clinically more effective than conventional methods and can generate savings for health systems. The platform has recorded more than 600,000 exercises performed by patients. Healthinn is supported by Andalucía Open Future, EIT Health and the S2B Health&Care program. The company plans to scale adoption into medium and small hospitals and clinics and to expand internationally to countries including Belgium, the UK and Italy. The recent financing will support broader clinical deployment and commercial expansion.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Oct 2020